Now this is the future of TB research 👏
39 Keystone Symposia & @gatesfoundation.bsky.social scholarship awardees at #KSTB26.
With ~1.5M TB deaths each year, these early-career scientists are driving progress through collaboration and new ideas.
@maxgg.bsky.social @breealdridge.bsky.social
Design and characterization of #HIV-1 #vaccine candidates to elicit antibodies targeting multiple epitopes. From Gristick, @bjorkman-lab.bsky.social et al.: rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Structural and genetic basis of #HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies. From Roark, Habib, Shaw, Kwong, Shapiro et al.: rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect. From Kyle Rhodehouse, Robert F. Siliciano and colleagues: rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Transcription of #HIV-1 is heterogenous among authentic latent CD4+ T cell clones, say Cintia Bittar, Michel C. Nussenzweig and colleagues: rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Day 1 of Keystone Tuberculosis: Understanding the Disease Across Scales. On #WorldTBDay #WTBD. So much good science, from immunology to host and pathogen genomics to antibiotic discovery and lung-on-chip organoid models #KSTB26
Deconvoluting the interplay of innate & adaptive immunity in BCG-induced nonspecific & #TB-specific host resistance. Perspective by @kerryhilligan.bsky.social et al rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Noncanonical T cell responses are associated with protection from #tuberculosis in mice and humans. From Proulx, Wiggins, Lauffenburger, Sassetti et al. rupress.org/jem/article/...
📘 Updates on the Immune Responses to #TB and #HIV: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Early and opposing #neutrophil and CD4 T cell responses shape pulmonary #tuberculosis pathology. From @bengern.bsky.social, Michael Gerner, Kevin Urdahl et al. rupress.org/jem/article/...
📘 Updates on the Immune Responses to #TB and #HIV: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Type I IFN drives #neutrophil swarming, impeding lung T cell–#macrophage interactions and #TB control. From William Branchett, Anne O’Garra and colleagues: rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis and #HIV: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Human CD4+ T cells recognize Mycobacterium #tuberculosis–infected #macrophages amid broader responses, from Stetsenko, Gail, Carpenter et al. rupress.org/jem/article/...
📘 Updates on the Immune Responses to #TB and #HIV: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Single-cell and spatial profiling highlights #TB-induced myofibroblasts as drivers of lung pathology. From Ian Mbano and colleagues @ahri-news.bsky.social rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis and #HIV: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
This collection highlights recent JEM studies investigating the adaptive and innate immune response induced by M. #tuberculosis and HIV-1 infection. Read new findings to accompany @keystonesymposia.bsky.social meetings on #TB and #HIV Vaccines: rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Experts across microbiology, cell biology, immunology, and clinical research will unite to tackle the global TB challenge. This @keystoneSymposia.bsky.social meeting highlights new technologies advancing our understanding of disease from bacteria to the human host.
buff.ly/1tdrFIP
#KSTB26
🔬 TB, infectious disease & global health researchers: Save $250 by registering for the Keystone Symposium on Tuberculosis by Jan 22 (11:59 PM MST). Join leaders in TB biology & global health. 🎥 youtu.be/4L_N79rDCfw
🔗 keysym.us/KSTB26
@maxgg.bsky.social @breealdridge.bsky.social #KSTB26 #TBResearch
Deadlines are approaching for the @keystonesymposia.bsky.social "Tuberculosis: Understanding the Disease Across Scales", this March in Cape Town! See abstract and discount reg dates: keysym.us/KSTB26 #KSTB26
Early Registration Deadline: January 22, 2026
Poster Abstract Deadline: March 2, 2026
Explore emerging research with field leaders @keystonesymposia.bsky.social #Tuberculosis: Understanding Disease Across Scales, March 2026 in Cape Town! keysym.us/KSTB26 #KSTB26 www.keystonesymposia.org/conferences/...
📢 Early-Career TB Researchers: Submit short talk abstracts & scholarship apps by Nov. 24! Join us Mar 23-26, 2026 in Cape Town for cutting-edge TB & global health. 🎥Highlights: youtu.be/YcKVeGWqXSM
Submit: keysym.us/KSTB26
@maxgg.bsky.social @breealdridge.bsky.social #KSTB26 #tuberculosis #TB
